Investors

Board of Directors

Florian  Schönharting, M.Sc. (Econ)
Chairman
Florian  Schönharting, M.Sc. (Econ)
Chairman


Florian Schönharting is a co-founder of the company and chairman of the board. He possesses over 22 years investment executive experience in both public and private equity funds in biotech and pharmaceuticals, co-founder of NB Capital, prior to this 10 years as key responsible for biopharma public and private investments, BankInvest Asset Management, Actively managed BI Healthcare SICAV and BI Bioteknologi SICAV for 8 years. Currently managed funds are NB Public Equity K/S, Nordic Biotech l &... 

Torsten Goesch, MD, PhD, MBA
Board member
Torsten Goesch, MD, PhD, MBA
Board member


Dr. Torsten Goesch is a director of Rosetta Capital, formerly BioScience Managers Limited (BML) which he joined in July 2002. Previously, Dr. Goesch was the founder and Managing Director of TRG Invest (1999-2002), a Munich-based consulting business providing companies in the life science sector with support in strategic management, business development, technology management, mergers & acquisitions, new market entries and fundraising. Dr. Goesch has a proven commercial track record in buildin... 

Grant Hellier Lawrence
Board member
Grant Hellier Lawrence
Board member


Grant Hellier Lawrence is currently Managing Director and CFO at Nunc A/S, a Thermo Fish- er Scientific company. He has more than 15 years of financial and IT management experi- ence within global Life Science manufacturing and commercial companies, where he has provided overall leadership and strategic direction with a proven record of driving sustained business and financial performance. Prior to joining Thermo Fisher Scientific, Mr Lawrence worked for FMC and Pioneer Electronic Corporation. M... 
Jakob Mosegaard Larsen
Board member
Jakob Mosegaard Larsen
Board member


Jakob Mosegaard Larsen is a partner at Copenhagen based law firm, Mazanti-Andersen Korsø Jensen LLP, and serves as a trusted advisor of Danish and international private equity and venture funds. He has several years of experience acting as a legal adviser of biotech and life science companies. He graduated from Copenhagen University with a Master Degree in Law and holds an executive MBA from Copenhagen Business School. Jakob MosegaardLarsen is a member of the Danish Venture Capital and Private E... 
Dr. Duncan Moore
Board member
Dr. Duncan Moore
Board member


Dr. Moore is a partner at East West Capital Partners since May 2008. Previously, Dr Moore was a top ranked pharmaceutical analyst at Morgan Stanley from 1991 to 2008 and was a Managing Director from 1997 to 2008 leading the firm’s global healthcare equity research team. Whilst at the University of Cambridge he co-founded a medical diagnostics company called Ultra Clone with two colleagues which led to the beginnings of a 20 year career in healthcare capital markets analysis. In 1986 he was invol...